Velten, MD, PhD (@radiationdoc) has used short-form video to make radiation oncology more understandable for her patients.

T-DXd achieves rapid antitumor activity in HER2-positive early breast cancer that deepens with subsequent paclitaxel plus trastuzumab plus pertuzumab.

Improved survival seen with addition of abiraterone for patients receiving androgen deprivation therapy + docetaxel ...

In this retrospective cohort study, researchers evaluated GLP-1 use among Medicare beneficiaries with type 2 diabetes and cancer compared to those with type 2 diabetes only.

Residential PM2.5 linked to positive end of induction minimal residual disease for patients with high-risk B-ALL ...

Researchers conducted a secret shopper study to identify logistical barriers young adults face when initiating outpatient care for leukemia.

This month featured ESMO updates, breast cancer trial news, social media strategies for oncologists, and mastectomy body image issues.

In patients with extensive-stage small cell lung cancer, adding tarlatamab to durvalumab maintenance therapy significantly ...

Researchers assessed preoperative lesion area as a predictor of final defect size in periocular basosquamous carcinoma cases.

Neoadjuvant therapy with trastuzumab deruxtecan is of only “modest” benefit in patients with HER2-low, HR+ early-stage breast ...

Racial disparities emerge across the entire breast cancer care continuum, from underlying metabolic health to survival rates ...

Updated findings from the OptimUM trials support the use of darovasertib plus crizotinib in the treatment of patients with ...